A citation-based method for searching scientific literature

Douglas E Levy, Judy E Garber, Alexandra E Shields. J Gen Intern Med 2009
Times Cited: 39







List of co-cited articles
183 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
L G Bluman, B K Rimer, D A Berry, N Borstelmann, J D Iglehart, K Regan, J Schildkraut, E P Winer. J Clin Oncol 1999
105
5

Acceptance, motivators, and barriers in attending breast cancer genetic counseling in Asians.
Tan-Min Chin, Sing-Huang Tan, Siew-Eng Lim, Philip Iau, Wei-Peng Yong, Seng-Weng Wong, Soo-Chin Lee. Cancer Detect Prev 2005
28
7

What do women really want to know? Motives for attending familial breast cancer clinics.
C J Van Asperen, S Van Dijk, M W Zoeteweij, D R M Timmermans, G H De Bock, E J Meijers-Heijboer, M F Niermeijer, M H Breuning, J Kievit, W Otten. J Med Genet 2002
54
5

BRCA testing of breast cancer patients: medical specialists' referral patterns, knowledge and attitudes to genetic testing.
E Van Riel, C C Wárlám-Rodenhuis, S Verhoef, E J T H Rutgers, M G E M Ausems. Eur J Cancer Care (Engl) 2010
38
5

Why do women attend familial breast cancer clinics?
K Brain, J Gray, P Norman, E Parsons, A Clarke, C Rogers, R Mansel, P Harper. J Med Genet 2000
85
5

Factors influencing patients' decisions to decline cancer genetic counseling services.
K P Geer, M E Ropka, W F Cohn, S M Jones, S Miesfeldt. J Genet Couns 2001
61
5

Awareness of genetic testing for cancer among United States Hispanics: the role of acculturation.
Julia E Heck, Rebeca Franco, Janine M Jurkowski, Sherri Sheinfeld Gorin. Community Genet 2008
26
7

Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.
Allison W Kurian, Bronislava M Sigal, Sylvia K Plevritis. J Clin Oncol 2010
153
5


Validation of family history data in cancer family registries.
Argyrios Ziogas, Hoda Anton-Culver. Am J Prev Med 2003
185
5

Characteristics of health information gatherers, disseminators, and blockers within families at risk of hereditary cancer: implications for family health communication interventions.
Laura M Koehly, June A Peters, Regina Kenen, Lindsey M Hoskins, Anne L Ersig, Natalia R Kuhn, Jennifer T Loud, Mark H Greene. Am J Public Health 2009
104
5


BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Tuya Pal, Jenny Permuth-Wey, Judith A Betts, Jeffrey P Krischer, James Fiorica, Hector Arango, James LaPolla, Mitchell Hoffman, Martin A Martino, Katie Wakeley,[...]. Cancer 2005
498
5

Screen positive rates among six family history screening protocols for breast/ovarian cancer in four cohorts of women.
Monica R McClain, Glenn E Palomaki, Heather Hampel, Judith A Westman, James E Haddow. Fam Cancer 2008
8
25



The role of financial factors in acceptance of clinical BRCA genetic testing.
Shannon Kieran, Lois J Loescher, Kyung Hee Lim. Genet Test 2007
32
6

Genetic testing in young women with breast cancer: results from a Web-based survey.
K J Ruddy, S Gelber, J Shin, J E Garber, R Rosenberg, M Przypysny, A H Partridge. Ann Oncol 2010
17
11

Paternal relatives and family history of breast cancer.
John M Quillin, Viswanathan Ramakrishnan, Joseph Borzelleca, Joann Bodurtha, Deborah Bowen, Diane Baer Wilson. Am J Prev Med 2006
22
9

Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.
M Cappelli, L Surh, L Humphreys, S Verma, D Logan, A Hunter, J Allanson. Clin Genet 1999
91
5

Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors.
Angela Trepanier, Mary Ahrens, Wendy McKinnon, June Peters, Jill Stopfer, Sherry Campbell Grumet, Susan Manley, Julie O Culver, Ronald Acton, Joy Larsen-Haidle,[...]. J Genet Couns 2004
144
5

Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center.
Brandie Heald, Thomas Plesec, Xiuli Liu, Rish Pai, Deepa Patil, Jessica Moline, Richard R Sharp, Carol A Burke, Matthew F Kalady, James Church,[...]. J Clin Oncol 2013
117
5


Family history-taking in community family practice: implications for genetic screening.
L S Acheson, G L Wiesner, S J Zyzanski, M A Goodwin, K C Stange. Genet Med 2000
176
5


Use of a web-based risk appraisal tool for assessing family history and lifestyle factors in primary care.
Heather J Baer, Louise I Schneider, Graham A Colditz, Hank Dart, Analisa Andry, Deborah H Williams, E John Orav, Jennifer S Haas, George Getty, Elizabeth Whittemore,[...]. J Gen Intern Med 2013
25
8

A cancer genetics toolkit improves access to genetic services through documentation and use of the family history by primary-care clinicians.
Maren T Scheuner, Alison B Hamilton, Jane Peredo, Taylor J Sale, Colletta Austin, Stuart C Gilman, M Scott Bowen, Caroline Lubick Goldzweig, Martin Lee, Brian S Mittman,[...]. Genet Med 2014
32
6

Hereditary cancer predisposition syndromes.
Judy E Garber, Kenneth Offit. J Clin Oncol 2005
321
5


Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.
Jeffrey A Tice, Steven R Cummings, Rebecca Smith-Bindman, Laura Ichikawa, William E Barlow, Karla Kerlikowske. Ann Intern Med 2008
335
5

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
H Meijers-Heijboer, B van Geel, W L van Putten, S C Henzen-Logmans, C Seynaeve, M B Menke-Pluymers, C C Bartels, L C Verhoog, A M van den Ouweland, M F Niermeijer,[...]. N Engl J Med 2001
631
5

Patient-reported hereditary breast and ovarian cancer in a primary care practice.
John M Quillin, Alexander H Krist, Maria Gyure, Rosalie Corona, Vivian Rodriguez, Joseph Borzelleca, Joann N Bodurtha. J Community Genet 2014
8
25

Using a state cancer registry to recruit young breast cancer survivors and high-risk relatives: protocol of a randomized trial testing the efficacy of a targeted versus a tailored intervention to increase breast cancer screening.
Maria C Katapodi, Laurel L Northouse, Ann M Schafenacker, Debra Duquette, Sonia A Duffy, David L Ronis, Beth Anderson, Nancy K Janz, Jennifer McLosky, Kara J Milliron,[...]. BMC Cancer 2013
17
11

Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.
Efrat Gabai-Kapara, Amnon Lahad, Bella Kaufman, Eitan Friedman, Shlomo Segev, Paul Renbaum, Rachel Beeri, Moran Gal, Julia Grinshpun-Cohen, Karen Djemal,[...]. Proc Natl Acad Sci U S A 2014
191
5

Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients.
Shilpa Grover, Elena M Stoffel, Laoti Bussone, Elizabeth Tschoegl, Sapna Syngal. Clin Gastroenterol Hepatol 2004
120
5

Cancer statistics, 2016.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2016
5

Genetic assessment of breast cancer risk in primary care practice.
Wylie Burke, Julie Culver, Linda Pinsky, Sarah Hall, Susan E Reynolds, Yutaka Yasui, Nancy Press. Am J Med Genet A 2009
52
5

Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.
Bronson D Riley, Julie O Culver, Cécile Skrzynia, Leigha A Senter, June A Peters, Josephine W Costalas, Faith Callif-Daley, Sherry C Grumet, Katherine S Hunt, Rebecca S Nagy,[...]. J Genet Couns 2012
187
5

Early adoption of BRCA1/2 testing: who and why.
Katrina Armstrong, Janet Weiner, Barbara Weber, David A Asch. Genet Med 2003
33
6

Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.
Patricia Ashton-Prolla, Juliana Giacomazzi, Aishameriane V Schmidt, Fernanda L Roth, Edenir I Palmero, Luciane Kalakun, Ernestina S Aguiar, Susana M Moreira, Erica Batassini, Vanessa Belo-Reyes,[...]. BMC Cancer 2009
39
5


The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group.
Steven M Teutsch, Linda A Bradley, Glenn E Palomaki, James E Haddow, Margaret Piper, Ned Calonge, W David Dotson, Michael P Douglas, Alfred O Berg. Genet Med 2009
464
5

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
487
5


Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers.
Claudia Marchetti, Francesca De Felice, Innocenza Palaia, Giorgia Perniola, Angela Musella, Daniela Musio, Ludovico Muzii, Vincenzo Tombolini, Pierluigi Benedetti Panici. BMC Womens Health 2014
87
5

Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
Deborah Cragun, Anne Weidner, Courtney Lewis, Devon Bonner, Jongphil Kim, Susan T Vadaparampil, Tuya Pal. Cancer 2017
84
5

Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.
Anne Marie McCarthy, Mirar Bristol, Susan M Domchek, Peter W Groeneveld, Younji Kim, U Nkiru Motanya, Judy A Shea, Katrina Armstrong. J Clin Oncol 2016
74
5

Family history in public health practice: a genomic tool for disease prevention and health promotion.
Rodolfo Valdez, Paula W Yoon, Nadeem Qureshi, Ridgely Fisk Green, Muin J Khoury. Annu Rev Public Health 2010
149
5



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.